<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> is one of the most common hereditary spinocerebellar <z:e sem="disease" ids="C1285162" disease_type="Disease or Syndrome" abbrv="">degenerative disorders</z:e> with a wide range of clinical manifestations </plain></SENT>
<SENT sid="1" pm="."><plain>Pathology studies have shown mild to moderate loss of anterior horn cells and, in terms of spinal pathology, <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> is regarded as a type of lower motoneuron disease </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0003394'>Muscle cramps</z:hpo> are often associated with lower motoneuron disorders, but features of cramps in <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> patients have never been studied </plain></SENT>
<SENT sid="3" pm="."><plain>We investigated the incidence and nature of <z:hpo ids='HP_0003394'>muscle cramps</z:hpo> in <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> patients, the excitability properties of motor axons [strength-duration time constant (tau(SD)), threshold electrotonus, refractoriness and supernormality] using threshold tracking and the effects of mexiletine <z:chebi fb="16" ids="36807">hydrochloride</z:chebi> on those cramps </plain></SENT>
<SENT sid="4" pm="."><plain>Of 20 consecutive patients, 16 (80%) had frequent, severe <z:hpo ids='HP_0003394'>muscle cramps</z:hpo> in the legs, trunk or arms that disturbed their daily activities </plain></SENT>
<SENT sid="5" pm="."><plain>The frequency of pathological <z:hpo ids='HP_0003394'>muscle cramps</z:hpo> was similar to that for patients with <z:hpo ids='HP_0007354'>amyotrophic lateral sclerosis</z:hpo> (68%) and higher than those for patients with <z:hpo ids='HP_0007269'>spinal muscular atrophy</z:hpo> (33%) or <z:hpo ids='HP_0003477'>peripheral axonal neuropathy</z:hpo> (24%) </plain></SENT>
<SENT sid="6" pm="."><plain>Threshold-tracking studies showed that tau(SD), which in part reflects <z:chebi fb="0" ids="29101">Na(+)</z:chebi> conductance at the resting membrane potential, was significantly greater in the <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> patients than in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects; severe <z:hpo ids='HP_0003394'>muscle cramps</z:hpo> were associated with a longer tau(SD) </plain></SENT>
<SENT sid="7" pm="."><plain>Threshold electrotonus, refractoriness and supernormality were not significantly different between <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> patients and <z:mpath ids='MPATH_458'>normal</z:mpath> subjects </plain></SENT>
<SENT sid="8" pm="."><plain>Eight <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> patients with severe cramps, who received mexiletine treatment, experienced nearly complete relief with a partial normalization of tau(SD) (P = 0.08) </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0003394'>Muscle cramps</z:hpo> are a very frequent and disabling factor in <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Pathological <z:hpo ids='HP_0003394'>muscle cramps</z:hpo> responded well to mexiletine treatment, and this is consistent with the hypothesis that they are caused by an increase in persistent <z:chebi fb="0" ids="29101">Na(+)</z:chebi> conductance, possibly associated with <z:hpo ids='HP_0003450'>axonal regeneration</z:hpo> or collateral sprouting </plain></SENT>
</text></document>